Optimizing Antiemetic Strategies Across Phases of Chemotherapy-Induced Nausea and Vomiting: Real-World Evidence in Breast Cancer.

Curr Oncol · 2026 · PMC12939676 · PMID 41744842

Europe PMC DOI

hedged sentence

0.0610

closest p · 1.2× alpha

0.0610

boldest claim

The sentences

did not reach statistical significancep = 0.061so close (0.05 < p ≤ 0.1)

During the acute phase (0–24 h), CR was achieved in 92.9% of patients receiving fosaprepitant and 85.7% of those receiving aprepitant; however, this difference did not reach statistical significance ( p = 0.061).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.